Concepedia

A prospective evaluation of the predictive value of faecal calprotectin in quiescent Crohn's disease

Graham Naismith, L Smith, Sarah Barry, Joanna Munro, Susan Laird, Karen Rankin, Allan J. Morris, Jack Winter, Daniel R. Gaya

Journal of Crohn s and Colitis · 2014 · 48 citations · 30 references

DOIFull text

Open access

Abstract

In this prospective dataset, FC is a useful tool to help identify quiescent Crohn's disease patients at a low risk of relapse over the ensuing 12 months. FC of 240 μg/g was the optimal cutoff in this cohort.

References

30

Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

William R. Best, Jack M. Becktel, John W. Singleton et al. · PubMed · 1976 · 3.2K citations

Development of a Crohn's Disease Activity Index

William R. Best, Jack M. Becktel, John W. Singleton et al. · Gastroenterology · 1976 · 3.1K citations

, , +2

Long-Term Evolution of Disease Behavior of Crohn's Disease

Jacques Cosnes, Stéphane Cattan, Antoine Blain et al. · Inflammatory Bowel Diseases · 2002 · 1.3K citations · Full text

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

Geert D’Haens, Marc Ferrante, Séverine Vermeire et al. · Inflammatory Bowel Diseases · 2012 · 797 citations · Full text

Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease

Jeremy Tibble, G Sigthorsson, Steven Bridger et al. · Gastroenterology · 2000 · 760 citations

, , +10